Evaluation and results of treatments for XXXX .

@entity1 @entity1069 @entity1494 @entity1344
@entity1 with symptoms of @entity1069 form a heterogenous group. The best treatment of proven obstruction or retention in fit @entity1 remains transurethral prostatectomy (TURP). @entity1 presenting with symptoms of @entity1069 may have @entity1494 , @entity1344 or @entity1494 leading to low pressure/low flow voiding so it is perhaps not surprising that only 75% of @entity1 selected for TURP purely on the basis of symptoms have a good outcome. Pressure flow studies are the only precise method of diagnosing outflow obstruction. The problem of accurately diagnosing obstruction before treatment is started applies particularly to trials of new treatments such as lasers, high energy focused ultrasound and drugs. Laser treatment is producing short term results that are slightly inferior to TURP but may have less morbidity. The role of conservative treatment is important in selected @entity1 . @entity1 who have severe intercurrent illness may be treated by means of intra-prostatic stents. In order to accurately assess a new treatment it is necessary to determine the short-term mortality, the morbidity, complication rate and outcome as well as the cost-effectiveness, long-term outcome and @entity1 preference. These conditions have not yet been met for any of the new treatments for @entity1069 .
